disease. J Vasc Surg 2010;52:1376-83.
189. Twine CP, Coulston J, Shandall A, McLain AD. Angioplasty versus
stenting for superﬁcial femoral artery lesions. Cochrane Database Syst
Rev 2009;(2):CD006767.
190. Rogers JH, Laird JR. Overview of new technologies for lower extremity revascularization. Circulation 2007;116:2072-85.
191. Lee LK, Kent KC. Infrainguinal occlusive disease: endovascular
intervention is the ﬁrst line therapy. Adv Surg 2008;42:193-204.
192. Wilson SE. Trials of endovascular treatment for superﬁcial femoral
artery occlusive lesions: a call for medically managed control patients.
Ann Vasc Surg 2010;24:498-502.
193. Hunink MG, Wong JB, Donaldson MC, Meyerovitz MF,
Harrington DP. Patency results of percutaneous and surgical

JOURNAL OF VASCULAR SURGERY
March Supplement 2015

revascularization for femoropopliteal arterial disease. Med Decis
Making 1994;14:71-81.
194. Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J,
Buchbinder M, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superﬁcial femoral artery and proximal
popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 2010;3:267-76.
195. Bergeron P, Pinot JJ, Poyen V, Benichou H, Khanoyan P,
Rudondy P, et al. Long-term results with the Palmaz stent in the
superﬁcial femoral artery. J Endovasc Surg 1995;2:161-7.
196. Geraght